Design and measuring the effect of an evidence-based Interventional Mapping on the level of self-management, self-efficacy, quality of life, distress, and experiences of living with type 2 diabetes of Iraqi employees: Mixed Method (hybrid design).

Evaluate the effect of a workplace evidence-based diabetes intervention mapping program on diabetes self-management, diabetes self-efficacy, diabetes-specific quality of life, and diabetes distress among Iraqi governmental employees with type 2 diabetes.

Two-arm, parallel-group, randomized controlled trial with 60 participants, 30 per group, allocated by block randomization; no placebo and not blinded.

The trial will be conducted in approved governmental hospital sites in Baghdad, Iraq. After written informed consent and baseline assessment, eligible governmental employees with type 2 diabetes will be allocated to intervention or control groups using block randomization. The intervention group will receive a structured workplace evidence-based diabetes intervention mapping program plus usual care, while the control group will receive usual care only. Outcomes will be measured at baseline and post-intervention using validated Arabic questionnaires. No formal blinding will be implemented because the intervention is educational and behavioral, so participants and intervention providers will know group allocation.

Iraqi governmental employees aged 30–60 years with confirmed type 2 diabetes for at least six months. Exclusions include other diabetes types, healthcare professionals, severe illness preventing participation, inability to complete questionnaires, planned absence before follow-up, or withdrawal of consent.

The intervention group will receive W-EBDIM plus usual care. The control group will receive usual care only. Allocation will use block randomization with a 1:1 ratio.

Main outcomes are diabetes self-management (DSMQ-R), self-efficacy (DSES), diabetes-specific quality of life (QOLSID), and diabetes distress (PAID-5), measured at baseline and post-intervention.

After eligibility confirmation, written informed consent, and baseline assessment, eligible participants will be assigned to the intervention or control group using computer-generated permuted block randomization with a 1:1 allocation ratio. The unit of randomization will be the individual participant. The random allocation sequence will be prepared by an independent statistician who is not involved in recruitment, intervention delivery, or outcome assessment. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes or an equivalent secure computerized allocation system. Group assignment will be revealed only after eligibility confirmation, consent, and baseline assessment have been completed.

Deidentified individual participant data will not be shared because the study involves health-related data from employees recruited from specific workplace and hospital settings. Even after deidentification, there may be a risk of indirect identification. Data sharing is also limited by the informed consent conditions and ethical approvals. Only aggregated results will be reported in publications and academic outputs.

The study protocol, statistical analysis plan, and blank informed consent form will be shared. These documents will not include identifiable participant information or individual participant-level data.

The documents will become available after publication of the main study results or completion of the doctoral dissertation, whichever occurs first, and will be available for five years.

The documents will be available to qualified researchers affiliated with academic or research institutions upon reasonable request.

Requests must include a clear academic or scientific purpose and must be consistent with ethical approvals, participant confidentiality, and institutional regulations. The documents may be used for research, protocol comparison, or methodological reference only.

Requests should be sent by email to the principal investigator: anasramaid@gmail.com (or Anas.karaghool@modares.ac.ir). Requests may also be reviewed in consultation with the study supervisor and Tarbiat Modares University.

The applicant should submit a written request explaining the requested document, purpose of use, affiliation, and planned use. The research team will review the request and provide the approved documents electronically if the request is appropriate.

No deidentified individual participant data will be shared.